Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ABCB1 genotyping in the treatment of depression.

Pharmacogenomics - 1 Dec 2016

Brückl Tanja Maria, Uhr Manfred

Abstract excerpt

P-glycoprotein (P-gp), the gene product of ABCB1, is a drug transporter at the blood-brain barrier and could be a limiting factor for entrance of antidepressants into the brain, the target site of antidepressant action. Animal studies showed that brain concentrations of many antidepressants depend on P-gp. In humans, ABCB1 genotyping in the treatment of depression rests on the assumption that genetic variations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Blood-Brain Barrier
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Transport and Resistance Mechanisms

Share to ABCB1 gene

Share to Genotype

Share to Pharmacological Effects and Toxicity Studies

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 27918249
DOI: 10.2217/pgs.16.18

Genes

ABCB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ABCB1 genotyping in the treatment of depression.PMID 27918249Read ↗

The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.Semantic proximity Read ↗

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.Semantic proximity Read ↗

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.Semantic proximity Read ↗

Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.Semantic proximity Read ↗

ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.Semantic proximity Read ↗

Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.Semantic proximity Read ↗

ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.Semantic proximity Read ↗

ABCB1 C1236T, G2677TA and C3435T Genetic Polymorphisms and Antidepressant Response Phenotypes: Results from a Portuguese Major Depressive Disorder Cohort.Semantic proximity Read ↗

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.Semantic proximity Read ↗

ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.Semantic proximity Read ↗

Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.Semantic proximity Read ↗

Interactions between antidepressants and P‐glycoprotein at the blood–brain barrier: clinical significance of in vitro and in vivo findingsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.